Fundraising Fox
AccurKardia
New York, US · Founded 2019 · Delaware corporation
Find your way into AccurKardia
Sign up to see every warm intro you have to AccurKardia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AccurKardia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AccurKardia develops AI-based technology for cardiac monitoring and ECG interpretation, serving clinicians and healthcare providers. It operates in the cardiology-focused medtech and digital health space.
Founders & leadership
AccurKardia was founded in 2019 by Juan C. Jimenez and Tony M Kuttiachen.
JC
Juan C. JimenezCo-Founder & CEOJuan C. Jimenez is co-founder and CEO of AccurKardia, which develops AI-based ECG interpretation and cardiac monitoring software for clinicians and healthcare providers.
MH
Moin HussainiChief Product OfficerChief Product Officer of AccurKardia, which develops AI-based cardiac monitoring and ECG interpretation technology for healthcare providers.
Funding
SEC filings, press & company announcements$4.1M disclosed across 1 of 2 rounds · 2022–2023
- Undisclosed amountSeedJun 2023Source ↗
▶$4.1MraisedJun 2023 · 41 investors · OtherRule 506(b)
▶$4.1MraisedJun 2023 · 41 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mohamed Sadeq AliDirector
- John FoxDirector
- Naveen SrinivasDirector
- Juan C JimenezExecutive Officer, Director
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 9
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
AliveCorAliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.
Aviary HealthAviary Health provides virtual and hybrid clinical programs — including cardiac rehabilitation, pulmonary rehabilitation, and chronic care management — combining AI-powered workflows with clinical teams. It serves hospitals and health systems, delivering end-to-end support for complex service lines.
BiotricityBiotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
CardiosenseCardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
SymKardiaSymKardia develops a selective cardiac neuromodulation therapy to treat cardiac arrhythmias such as atrial fibrillation, targeting the nervous system rather than only cardiac tissue. It is a clinical-stage cardiovascular medical device company running pre-clinical and clinical research programs.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
ComKardiaComKardia is developing an AI-powered decision-support platform for coronary artery disease and PCI planning that builds a patient-specific digital twin to help interventional cardiologists plan stent selection, sizing, and placement within the cath lab workflow. The company targets interventional cardiology and plans to distribute its imaging-guided PCI software through a licensing and SaaS model.
DigitalDigital.Health is a clinician-curated discovery platform where clinicians, health systems, and consumers find, compare, and select digital health solutions. It offers structured company and product listings that feed its comparison engine, recommendation system, and AI-enabled search for buyers in active evaluation.
Companies working in the same space as AccurKardia.
In the news
Frequently asked questions
- What does AccurKardia do?
- AccurKardia develops AI-based technology for cardiac monitoring and ECG interpretation, serving clinicians and healthcare providers. It operates in the cardiology-focused medtech and digital health space.
- Who founded AccurKardia?
- AccurKardia was founded by Juan C. Jimenez, Tony M Kuttiachen in 2019.
- How much funding has AccurKardia raised?
- AccurKardia has disclosed $4.1M raised across 1 of its 2 known rounds.
- Where is AccurKardia headquartered?
- AccurKardia is headquartered in New York, US.